Xialla Featured in the International Journal of Impotence Research

In August 2023, the International Journal of Impotence Research (IJIR) published a perspective article on Xialla as a medical device for erectile dysfunction associated with veno-occlusive dysfunction (venous leak). The print citation is 2024.

Authored by urologists Faysal A. Yafi, Muhammed A. M. Hammad, and Dean Elterman, the article describes Xialla as an FDA-registered Class II wearable device designed to address venous leak — a common and historically difficult cause of erectile dysfunction. A perspective article is not a large randomized trial; it summarizes design rationale and early clinical series.

Veno-occlusive dysfunction

The perspective describes venous leak as an etiological factor contributing to approximately 75% of erectile dysfunction cases, citing Kaba and Pearce. In this condition, the veins that normally close during erection fail to do so effectively, allowing blood to leave the penis too quickly and preventing a firm, sustained erection.

Traditional constriction rings have been used for decades, but many patients find them uncomfortable, difficult to apply, or prone to slipping during activity. The IJIR perspective discusses how Xialla was developed to address those limitations through anchoring and material choices.

Clinical series cited in the article

The authors reference two small clinical evaluations:

• A study led by Dr. Anthony J. Bella and presented at the World Meeting on Sexual Medicine 2016 reported improvement in erectile function in 14 of 21 patients (66%) using the device.
• A subsequent evaluation of men with veno-occlusive dysfunction who had failed other treatments reported satisfactory salvage of erectile function in 6 of 11 patients (54%).

These are small series. They support further study and suggest benefit for a subset of men who have not responded adequately to conventional approaches; they are not large multicenter trials.

Design features discussed

The IJIR article emphasizes several features that differentiate Xialla from traditional penile constriction rings:

• Application flexibility — The device can be applied whether the penis is erect or flaccid.
• Securing mechanism — A loop and adhesive pad system anchors the ring in place, reducing movement and associated venous leakage during activity.
• Comfort — Soft medical-grade silicone allows venous occlusion without requiring an excessively tight fit.
• Profile — The design aims for routine usability and discretion alongside function.

These elements are intended to improve blood retention while keeping compression low enough to preserve arterial inflow — two factors that have historically limited the usefulness of standard constriction devices. For mechanism detail, see Blood Retention: How Xialla Reduces Venous Outflow.

Additional clinical applications

Beyond primary erectile dysfunction, the article notes that Xialla has been evaluated in a small clinical series for climacturia (involuntary urine leakage during orgasm following prostate surgery). In that series of five men who had failed other non-surgical approaches, all reported improvement, with four experiencing complete resolution of leakage during activity while wearing the device. That series is too small to generalize; it is a signal for further study.

The authors also observe that Xialla can be used together with other erectile dysfunction therapies, including oral medications, intracavernosal injections, and vacuum erection devices.

Safety

As with any constriction device, prolonged wear or failure to remove the device can lead to penile ischemia. Maximum continuous wear is 30 minutes; remove before sleeping; remove immediately if numbness, coldness, discoloration, or pain occurs. Men taking anticoagulants, men with sickle cell disease, and men with reduced penile sensation should consult a physician before use. See using a constriction device safely.

What peer-reviewed publication adds

Publication in International Journal of Impotence Research places the design rationale and early clinical series in a peer-reviewed venue that sexual-medicine clinicians read. It does not by itself establish comparative effectiveness against other treatments. For men with erectile dysfunction related to veno-occlusive dysfunction, and for the clinicians who care for them, the perspective is one source of context among guidelines, diagnostic workup, and individual trial of appropriate options.

Related reading

• Blood Retention: Reducing Venous Outflow
• Girth and Firmness Through Blood Retention
• Skin Tension and Stretch-Sensitive Nerves
• Skin Slack and Direct Contact During Intercourse
• Clinical research supporting Xialla

References

• Yafi FA, Hammad MAM, Elterman D. Xialla®: a novel medical device for addressing erectile dysfunction associated with veno-occlusive dysfunction. Int J Impot Res. 2024;36:551–552. https://doi.org/10.1038/s41443-023-00754-w
• Kaba R, Pearce I. Venous leak and erectile dysfunction: an important differential. J Clin Urol. 2020;13(1):33–39.

If you have questions about anything in this article, write to us at hello@xialla.com. We read and answer every message.